Neprilysin Protects against Cerebral Amyloid Angiopathy and Aβ-Induced Degeneration of Cerebrovascular Smooth Muscle Cells
Article first published online: 3 APR 2011
© 2011 The Authors. Brain Pathology © 2011 International Society of Neuropathology
Volume 21, Issue 5, pages 594–605, September 2011
How to Cite
Miners, J. S., Kehoe, P. and Love, S. (2011), Neprilysin Protects against Cerebral Amyloid Angiopathy and Aβ-Induced Degeneration of Cerebrovascular Smooth Muscle Cells. Brain Pathology, 21: 594–605. doi: 10.1111/j.1750-3639.2011.00486.x
- Issue published online: 19 AUG 2011
- Article first published online: 3 APR 2011
- Accepted manuscript online: 8 MAR 2011 02:13AM EST
- Received 17 November 2010; accepted 15 February 2011.
Figure S1. The tissue pelleted after homogenization, filtration and sucrose gradient ultracentrifugation of a sample of cerebral cortex consists largely of blood vessels. The bar indicates 250 μm.
Figure S2. Western blot analysis of control and AD brain tissue homogenates shows a major reactive band with an apparent molecular mass of 40 kDa, which is consistent with the predicted molecular weight of smooth muscle actin (SMA). Lane 1 shows molecular weight markers; lanes 3, 5 and 7 are from AD cases; and 2, 4 and 6 from control brains. The membrane was probed with rabbit polyclonal antibody to SMA (1 in 500) (Abcam, Cambridge, UK).
Figure S3. Cerebrovascular smooth muscle cells (CVSMCs) immunolabeled for (A) smooth muscle actin (1:100) and (B) neprilysin (1:20) (Santa Cruz Biotechnology, Tebu Bio, Cambs, UK). The CVSMCs were grown on poly-L-lysine (Sciencell, TCS Cellworks, Bucks, UK)-coated glass coverslips, fixed in 4% paraformaldehyde, washed and incubated with ice-cold 70% methanol for 5 minutes and 10% donkey serum (Millipore, Watford, UK) for 45 minutes. The primary antibodies were added and left at 4°C overnight. Secondary antibody conjugated to alexa-fluor 488 (1:500) (Invitrogen, Paisley, UK) was added for 1 hour at room temperature. Images were obtained under a ×60 objective.
|BPA_486_sm_fS1.jpg||391K||Supporting info item|
|BPA_486_sm_fS2.jpg||29K||Supporting info item|
|BPA_486_sm_fS3.jpg||452K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.